IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-03
DOI
10.1038/s41598-021-82377-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsis
- (2019) Seung Jun Lee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production
- (2018) Hee Jo Park et al. JOURNAL OF NATURAL PRODUCTS
- Double-slit photoelectron interference in strong-field ionization of the neon dimer
- (2018) Maksim Kunitski et al. Nature Communications
- Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyrase
- (2017) Scott S. Walker et al. PLoS One
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Advances in the development of histone lysine demethylase inhibitors
- (2015) Tamara Maes et al. CURRENT OPINION IN PHARMACOLOGY
- Mechanism of Quinolone Action and Resistance
- (2014) Katie J. Aldred et al. BIOCHEMISTRY
- Targeting histone lysine demethylases — Progress, challenges, and the future
- (2014) Cyrille C. Thinnes et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation
- (2013) Richard J. Hopkinson et al. Chemical Science
- Brain-Penetrant LSD1 Inhibitors Can Block Memory Consolidation
- (2011) Ramesh Neelamegam et al. ACS Chemical Neuroscience
- Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
- (2011) Frédéric Collin et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Inhibition of 2-oxoglutarate dependent oxygenases
- (2011) Nathan R. Rose et al. CHEMICAL SOCIETY REVIEWS
- Epigenetic regulation of immune cell functions during post-septic immunosuppression
- (2011) William F. Carson et al. Epigenetics
- Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches
- (2010) Nathan R. Rose et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors
- (2010) Oliver N. F. King et al. PLoS One
- Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II Topoisomerases
- (2008) M. T. Black et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
- (2008) P. A.C. Cloos et al. GENES & DEVELOPMENT
- In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus
- (2008) B. T. Tsuji et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started